[go: up one dir, main page]

BG50281A3 - Метод за получаване на рекомбинантн днк експресионен вектор - Google Patents

Метод за получаване на рекомбинантн днк експресионен вектор

Info

Publication number
BG50281A3
BG50281A3 BG083181A BG8318188A BG50281A3 BG 50281 A3 BG50281 A3 BG 50281A3 BG 083181 A BG083181 A BG 083181A BG 8318188 A BG8318188 A BG 8318188A BG 50281 A3 BG50281 A3 BG 50281A3
Authority
BG
Bulgaria
Prior art keywords
preparation
expression vector
dna expression
activity
recombination dna
Prior art date
Application number
BG083181A
Other languages
English (en)
Inventor
Thomas Ingolia
Stephen Queener
Suellen Samson
Paul Skatrud
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG50281A3 publication Critical patent/BG50281A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Методът намира приложение за получаване на деацетоксицефалоспорин с синтетаза и деацетилцефалоспорин с синтетазни активност. По него се получават съединения с високи активности при висок добив на крайния продукт както в свободни клетъчни екстракти, така и в гастроприемник, различен от сернаlоsроriuм. При метода се конструира вектор за експресния на dасs/dаосs активност в сернаlоsроriuм,който включва кодираща съответната активност dнк последователност, и dнк последователност, кодираща промотор и активираща транслацията.3 претенции, 33 фигури
BG083181A 1987-03-04 1988-03-01 Метод за получаване на рекомбинантн днк експресионен вектор BG50281A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2183687A 1987-03-04 1987-03-04

Publications (1)

Publication Number Publication Date
BG50281A3 true BG50281A3 (bg) 1992-06-15

Family

ID=21806425

Family Applications (1)

Application Number Title Priority Date Filing Date
BG083181A BG50281A3 (bg) 1987-03-04 1988-03-01 Метод за получаване на рекомбинантн днк експресионен вектор

Country Status (17)

Country Link
US (1) US6180361B1 (bg)
EP (1) EP0281391B1 (bg)
JP (1) JPS63301790A (bg)
KR (1) KR960015264B1 (bg)
CN (1) CN1026015C (bg)
AU (1) AU608572B2 (bg)
BG (1) BG50281A3 (bg)
CA (1) CA1327170C (bg)
DE (1) DE3855633T2 (bg)
DK (1) DK102088A (bg)
ES (1) ES2095204T3 (bg)
FI (1) FI880888A (bg)
GR (1) GR3022094T3 (bg)
HU (1) HU205387B (bg)
IL (1) IL85535A (bg)
RU (1) RU1838413C (bg)
SU (1) SU1739856A3 (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
US6258555B1 (en) 1987-12-09 2001-07-10 Beecham Group P.L.C. DNA encoding ACV synthetase
US5162228A (en) * 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
EP0437378B1 (en) * 1990-01-12 1999-05-19 Glaxo Group Limited DNA sequence for an antibiotic biosynthesis enzyme
JPH03254684A (ja) * 1990-03-02 1991-11-13 Asahi Chem Ind Co Ltd 新規ｃＤＮＡ化合物
CA2045951A1 (en) * 1990-07-06 1992-01-07 Steven Kovacevic Recombinant dna expression vectors and dna compounds that encode deacetylcephalosporin c synthase activity
HU219370B (en) * 1991-10-15 2001-03-28 Gist Brocades Bv Novel bioprocesses for preparing 7-aca and 7-adac
WO2004113508A1 (en) * 2003-06-20 2004-12-29 Dsm Ip Assets B.V. Production of cephalosporin intermediates in penicillium chrysogenum
EP1819813A2 (en) * 2004-12-10 2007-08-22 DSMIP Assets B.V. Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms
WO2013105030A1 (en) 2012-01-10 2013-07-18 Orchid Chemicals And Pharmaceuticals Limited Mutated cephalosporin hydroxylase and its application in deacetylcephalosporanic acid synthesis
CN103421727B (zh) * 2012-05-22 2016-03-30 上海医药工业研究院 一种转化头孢菌素c的基因工程菌及其制备方法
CN107557348B (zh) 2016-07-01 2022-07-08 百瑞全球有限公司 头孢菌素羟化酶突变体、编码该突变体的dna、使用该突变体的方法及其应用
CN111424030A (zh) * 2020-03-13 2020-07-17 常州艾米能斯生物科技有限公司 一种大规模回收线性化质粒的方法
CN112852907B (zh) * 2020-03-16 2021-11-30 中国科学院天津工业生物技术研究所 一种头孢菌素c生产菌及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178210A (en) 1977-03-07 1979-12-11 Massachusetts Institute Of Technology Accellular synthesis of cephalosporins
US4307192A (en) * 1979-05-17 1981-12-22 Massachusetts Institute Of Technology Cell-free synthesis of deacetoxycephalosporin C
US4762786A (en) 1984-09-27 1988-08-09 Eli Lilly And Company Vectors and conditions which allow genetic transformation of cephalosporium
EP0191221A1 (en) 1984-10-24 1986-08-20 The Regents Of The University Of California Vectors for transformation of ascomycetes
RU1780542C (ru) 1985-04-22 1992-12-07 Эли Лилли Энд Компани Способ конструировани рекомбинантной плазмидной ДНК pPS 20, кодирующей изопенициллин-N-синтетазу, способ получени штамма СернаLоSроRIUм асRемоNIUм, обладающего активностью изопенициллин-N-синтетазы
IL78531A0 (en) * 1985-04-22 1986-08-31 Lilly Co Eli Recombinant dna expression vectors and dna compounds which encode isopenicillin n synthetase
US4874703A (en) * 1985-08-26 1989-10-17 Eli Lilly And Company Expression vectors for use in E. coli
US4892819A (en) * 1985-11-25 1990-01-09 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from penicillium chrysogenum
US4753881A (en) 1986-09-10 1988-06-28 Eli Lilly And Company Purified enzyme and process therefor

Also Published As

Publication number Publication date
HU205387B (en) 1992-04-28
KR960015264B1 (ko) 1996-11-07
DK102088D0 (da) 1988-02-26
EP0281391A1 (en) 1988-09-07
AU608572B2 (en) 1991-04-11
SU1739856A3 (ru) 1992-06-07
EP0281391B1 (en) 1996-10-30
IL85535A (en) 1994-02-27
RU1838413C (ru) 1993-08-30
JPS63301790A (ja) 1988-12-08
FI880888A0 (fi) 1988-02-25
US6180361B1 (en) 2001-01-30
IL85535A0 (en) 1988-08-31
DE3855633T2 (de) 1997-03-20
ES2095204T3 (es) 1997-02-16
AU1255788A (en) 1988-09-15
CA1327170C (en) 1994-02-22
FI880888A (fi) 1988-09-05
GR3022094T3 (en) 1997-03-31
DK102088A (da) 1988-12-16
DE3855633D1 (de) 1996-12-05
KR880011337A (ko) 1988-10-27
CN1026015C (zh) 1994-09-28
HUT46359A (en) 1988-10-28
CN88101644A (zh) 1988-11-23

Similar Documents

Publication Publication Date Title
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
KR890700658A (ko) 아스타크산틴-생산 효모 세포, 그의 제조방법 및 용도
ES8607388A1 (es) Un metodo para preparar que tiene sustancialmente la misma secuencia de aminoacidos que la superoxido-dismutasa humana.
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
AU692678B2 (en) Structural gene of pneumococcal protein
ES2006925A6 (es) Procedimiento para la preparacion de vectores de expresion.
ES2013324A6 (es) Un metodo mejorado para producir una proteina heterologa.
IL83192A0 (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
ES8800347A1 (es) Metodo para preparar uroquinasa de una sola cadena resistente a proteasas
OA09116A (en) Novel protein, sequences containing the gene therefore vectors, methods of preparation and use.
NO854448L (no) Sv40 ekspresjonsvektor inneholdende hbxag som en ekspresjonsmarkoer.
HU896734D0 (en) Process for the preparation of dna encoding for isopenicillin n epimerase (racemase) and recombinant dna expression vector
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
IL80511A0 (en) Multiply amplifiable vectors for high level expression of exogenous dna
IL86058A0 (en) Production of proteins
IL97000A0 (en) Recombinant dna expression vectors and dna compounds that encode isopenicillin n epimerase activity
ATE189479T1 (de) Expressionsvektoren zur synthese von proteinen in der spalthefe schizosaccharomyces pombe
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase
Chappell The azimuth of language: explorations into the limits of expression
ES8800342A1 (es) Procedimiento para preparar un vector de levadura de copias multiples,estables y recombinante
ES2001042A6 (es) Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos
SU811519A1 (ru) Способ получения белкового раствора